Paper24782871
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
Haabeth OA and 10 others. Front Immunol, 2014. Cited by 161 papers, by iCite.
Cite this record
ConductScience Library. How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? Papers, record 24782871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24782871
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16179369 | Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. | Blood | 2006 | https://conductscience.org/library/papers/16179369 | PubMed |
| 2 | 4177521 | Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315. | Biochemistry | 1968 | https://conductscience.org/library/papers/4177521 | PubMed |
| 3 | 7931066 | Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. | J Exp Med | 1994 | https://conductscience.org/library/papers/7931066 | PubMed |
| 4 | 10411927 | CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10411927 | PubMed |
| 5 | 3096740 | Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. | Eur J Immunol | 1986 | https://conductscience.org/library/papers/3096740 | PubMed |
| 6 | 10894167 | CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. | Immunity | 2000 | https://conductscience.org/library/papers/10894167 | PubMed |
| 7 | 10981969 | Eradication of established tumors by CD8+ T cell adoptive immunotherapy. | Immunity | 2000 | https://conductscience.org/library/papers/10981969 | PubMed |
| 8 | 22383793 | Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice. | Blood | 2012 | https://conductscience.org/library/papers/22383793 | PubMed |
| 9 | 18026089 | Adaptive immunity maintains occult cancer in an equilibrium state. | Nature | 2007 | https://conductscience.org/library/papers/18026089 | PubMed |
| 10 | 12407407 | Natural selection of tumor variants in the generation of "tumor escape" phenotypes. | Nat Immunol | 2002 | https://conductscience.org/library/papers/12407407 | PubMed |
| 11 | 4921480 | The concept of immunological surveillance. | Prog Exp Tumor Res | 1970 | https://conductscience.org/library/papers/4921480 | PubMed |
| 12 | 12242449 | Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. | Science | 2002 | https://conductscience.org/library/papers/12242449 | PubMed |
| 13 | 23933259 | Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells. | Cell Rep | 2013 | https://conductscience.org/library/papers/23933259 | PubMed |
| 14 | 20178101 | "Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy. | Int J Cancer | 2010 | https://conductscience.org/library/papers/20178101 | PubMed |
| 15 | 1900037 | Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression. | Cancer Res | 1991 | https://conductscience.org/library/papers/1900037 | PubMed |
| 17 | 9553774 | Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. | Immunol Cell Biol | 1998 | https://conductscience.org/library/papers/9553774 | PubMed |
| 18 | 6749856 | The signal sequence of ovalbumin is located near the NH2 terminus. | J Biol Chem | 1982 | https://conductscience.org/library/papers/6749856 | PubMed |
| 19 | 22318521 | Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. | Nature | 2012 | https://conductscience.org/library/papers/22318521 | PubMed |
| 20 | 6208035 | Cloned helper T cells can kill B lymphoma cells in the presence of specific antigen: Ia restriction and cognate vs. noncognate interactions in cytolysis. | Eur J Immunol | 1984 | https://conductscience.org/library/papers/6208035 | PubMed |
| 21 | 8016643 | Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. | Science | 1994 | https://conductscience.org/library/papers/8016643 | PubMed |
Cited by115
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 161 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42027953 | Molecular origin, discovery, validation and application of neoantigens. | Asian J Pharm Sci | 2026 | https://conductscience.org/library/papers/42027953 | PubMed |
| 41836358 | Crosstalk between autophagy and apoptosis in initiating antitumor immune responses in human lymphoma cells. | Explor Immunol | 2025 | https://conductscience.org/library/papers/41836358 | PubMed |
| 41834910 | Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and combination therapy in advanced melanoma: A systematic review and meta-analysis. | EXCLI J | 2026 | https://conductscience.org/library/papers/41834910 | PubMed |
| 41659739 | Mendelian Randomization Combined with Bioinformatics Revealed Specific Allergy-Mediated Protective Mechanisms Against Renal Cell Carcinoma. | Phenomics | 2025 | https://conductscience.org/library/papers/41659739 | PubMed |
| 40804146 | In Silico Development of a Multi-epitope Vaccine Targeting TFDP3: A Novel Approach for Cancer Immunotherapy. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/40804146 | PubMed |
| 40746387 | Protective and Susceptibility Effects of Human Leukocyte Antigen on Melanoma Prevalence and their Implications for Predicting Checkpoint Blockade Immunotherapy Outcomes. | J Immunol Sci | 2022 | https://conductscience.org/library/papers/40746387 | PubMed |
| 40379687 | Asterias amurensis lipids enhance the immunity of immunosuppressed mice as sustainable marine-eco materials. | Sci Rep | 2025 | https://conductscience.org/library/papers/40379687 | PubMed |
| 40281615 | Unique transcriptomic responses of rat and human alveolar macrophages in an in vitro model of overload with TiO2 and carbon black. | Part Fibre Toxicol | 2025 | https://conductscience.org/library/papers/40281615 | PubMed |
| 40248717 | Closer proximity of pre-treatment CD4+ T cells to CD8+ T cells favor response to neoadjuvant immunotherapy in patients with PD-L1 low-expressing non-small cell lung cancer. | Transl Lung Cancer Res | 2025 | https://conductscience.org/library/papers/40248717 | PubMed |
| 40129873 | DNA-PKcs Dysfunction Enhances the Antitumor Activity of Radioimmunotherapy by Activating the cGAS-STING Pathway in HNSCC. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40129873 | PubMed |
| 39720956 | Cancer vaccines: an update on recent achievements and prospects for cancer therapy. | Clin Exp Med | 2024 | https://conductscience.org/library/papers/39720956 | PubMed |
| 39673127 | Potentiating CAR-T cell function in the immunosuppressive tumor microenvironment by inverting the TGF-β signal. | Mol Ther | 2025 | https://conductscience.org/library/papers/39673127 | PubMed |
| 39106430 | Anti-CTLA-4 treatment suppresses hepatocellular carcinoma growth through Th1-mediated cell cycle arrest and apoptosis. | PLoS One | 2024 | https://conductscience.org/library/papers/39106430 | PubMed |
| 39086686 | Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors. | Front Mol Med | 2023 | https://conductscience.org/library/papers/39086686 | PubMed |
| 39039195 | Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model. | Cancer Gene Ther | 2024 | https://conductscience.org/library/papers/39039195 | PubMed |
| 38920557 | Antimelanoma Effects of Alchemilla vulgaris: A Comprehensive In Vitro and In Vivo Study. | Diseases | 2024 | https://conductscience.org/library/papers/38920557 | PubMed |
| 38545119 | Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/38545119 | PubMed |
| 38287290 | Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38287290 | PubMed |
| 38146419 | Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy. | Breast Cancer (Dove Med Press) | 2023 | https://conductscience.org/library/papers/38146419 | PubMed |
| 37671471 | A Wrinkle in TIME: How Changes in the Aging ECM Drive the Remodeling of the Tumor Immune Microenvironment. | Cancer Discov | 2023 | https://conductscience.org/library/papers/37671471 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CTAG1A | 246100 | PubTator's text mining | https://conductscience.org/library/genes/246100 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24782871
GET https://conductscience.org/api/papers/v1/24782871/references?page=2